Clinical Trial: VV-14300 for the Treatment of Type 1 Diabetes

U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07831798) titled 'VV-14300 for the Treatment of Type 1 Diabetes' on Aug. 31.

Brief Summary: This study is testing VV-14300 in adults with long-standing type 1 diabetes (T1D) whose blood sugar is not well controlled despite using an automated insulin delivery (AID) system. VV-14300 is an investigational gene therapy that is injected into muscle and is designed to help remove excess sugar from the blood.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Type 1 Diabetes Mellitus

Intervention: GENETIC: VV-14300

VV-14300 will be administered via ultrasound-guided intramuscular injections

Recruitment Status: NOT_YET_RECRUITING

S...